National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

DJ-927
A semi-synthetic, orally bioavailable taxane derivative with potential antineoplastic properties. Oral taxane derivative DJ-927 binds to tubulin, promoting microtubule assembly and stabilization and preventing microtubule depolymerization, thereby inhibiting cell proliferation. As it represents poor substrate for P-glycoprotein-related drug resistance mechanisms, this agent may be useful for treating multi-drug resistant tumors. As the first oral taxane derivative, oral taxane derivative DJ-927 is more potent than paclitaxel and docetaxel. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:oral taxane derivative DJ-927
Code name:DJ927



Previous:Diprivan, dipyridamole, disaccharide tripeptide glycerol dipalmitoyl, Disalcid, disulfiram
Next:DM4-conjugated anti-Cripto monoclonal antibody BIIB015, DNA plasmid vector pPRA-PSM vaccine, docetaxel, docetaxel emulsion ANX-514, dolasetron mesylate

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov